Clover Health Investments (CLOV) Current Deferred Revenue (2022 - 2024)

Clover Health Investments (CLOV) has 3 years of Current Deferred Revenue data on file, last reported at $17000.0 in Q3 2024.

• For the quarter ending Q3 2024, Current Deferred Revenue fell 99.98% year-over-year to $17000.0; the trailing twelve-month figure through Sep 2024 stood at $17000.0 (down 99.98% YoY), and the FY2023 full-year result was $3.1 million, changed N/A from the prior year.
• Current Deferred Revenue for Q3 2024 stood at $17000.0, up from $13000.0 in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $113.5 million in Q2 2023 and bottomed at $13000.0 in Q2 2024.
• The 3-year median for Current Deferred Revenue is $96.4 million (2022), against an average of $60.6 million.
• The widest annual swing landed in 2023, when Current Deferred Revenue advanced 7.2%; it then plunged 99.99% in 2024.
• A 3-year view of Current Deferred Revenue shows it stood at $96.4 million in 2022, then sank by 96.78% to $3.1 million in 2023, then plunged by 99.45% to $17000.0 in 2024.
• The last three Current Deferred Revenue figures came in at $17000.0 (Q3 2024), $13000.0 (Q2 2024), and $3.1 million (Q4 2023), per Business Quant data.

Peer Comparison